However, there are discrepancies regarding the systemic effects of NOX2 activity in obesity, with one study also reporting adverse systemic effects, such as hyperphagia, elevated obesity, hepatic steatosis, and inflammation, together with exacerbated insulin resistance in obese NOX2 KO mice [41]. The gene discussed is CYBB; the disease is obesity disorder.